Hernigou Ph, Mathieu G, Poignard A, Manicom O, Beaujean F, Rouard H
Service de Chirurgie Orthopédique, Hôpital Henri Mondor, 94010 Creteil, France.
J Bone Joint Surg Am. 2006 Sep;88 Suppl 1 Pt 2:322-7. doi: 10.2106/JBJS.F.00203.
Bone marrow aspirated from the iliac crest contains progenitor cells that can be used to obtain bone-healing of nonunions. However, there is little available information regarding the number and concentration of these cells that are necessary to obtain bone repair. The purpose of this study was to evaluate the number and concentration of progenitor cells that were transplanted for the treatment of nonunion, the callus volume obtained after the transplantation, and the clinical healing rate.
Marrow was aspirated from both anterior iliac crests, concentrated on a cell separator, and then injected into sixty noninfected atrophic nonunions of the tibia. Each nonunion received a relatively constant volume of 20 cm(3) of concentrated bone marrow. The number of progenitor cells that was transplanted was estimated by counting the fibroblast colony-forming units. The volume of mineralized bone formation was determined by comparing preoperative computerized tomography scans with scans performed four months following the injection.
The aspirates contained an average (and standard deviation) of 612 +/- 134 progenitors/cm(3) (range, 12 to 1224 progenitors/cm(3)) before concentration and an average of 2579 +/- 1121 progenitors/cm(3) (range, 60 to 6120 progenitors/cm(3)) after concentration. An average total of 51 x 10(3) fibroblast colony-forming units was injected into each nonunion. Bone union was obtained in fifty-three patients, and the bone marrow that had been injected into the nonunions of those patients contained >1500 progenitors/cm(3) and an average total of 54,962 +/- 17,431 progenitors. The concentration (634 +/- 187 progenitors/cm(3)) and the total number (19,324 +/- 6843) of progenitors injected into the nonunion sites of the seven patients in whom bone union was not obtained were both significantly lower (p = 0.001 and p < 0.01, respectively) than those in the patients who obtained bone union. The volume of the mineralized callus measured at four months on the computerized tomography scans of the patients who had union ranged from 0.8 to 5.3 cm(3) (mean, 3.1 cm(3)). There was a positive correlation between the volume of mineralized callus at four months and the number (p = 0.04) and concentration (p = 0.01) of fibroblast colony-forming units in the graft. There was a negative correlation between the time needed to obtain union and the concentration of fibroblast colony-forming units in the graft (p = 0.04).
Percutaneous autologous bone-marrow grafting is an effective and safe method for the treatment of an atrophic tibial diaphyseal nonunion. However, its efficacy appears to be related to the number of progenitors in the graft, and the number of progenitors available in bone marrow aspirated from the iliac crest appears to be less than optimal in the absence of concentration.
从髂嵴抽取的骨髓含有祖细胞,可用于促进骨不连的骨愈合。然而,关于获得骨修复所需的这些细胞的数量和浓度,几乎没有可用信息。本研究的目的是评估用于治疗骨不连的祖细胞的数量和浓度、移植后获得的骨痂体积以及临床愈合率。
从双侧髂嵴抽取骨髓,在细胞分离器上进行浓缩,然后注入60例未感染的胫骨萎缩性骨不连患者体内。每个骨不连部位注入相对恒定体积的20 cm³浓缩骨髓。通过计数成纤维细胞集落形成单位来估计移植的祖细胞数量。通过比较术前计算机断层扫描与注射后四个月进行的扫描来确定矿化骨形成的体积。
浓缩前,抽吸物中平均(及标准差)含有612±134个祖细胞/cm³(范围为12至1224个祖细胞/cm³),浓缩后平均含有2579±1121个祖细胞/cm³(范围为60至6120个祖细胞/cm³)。每个骨不连部位平均共注入51×10³个成纤维细胞集落形成单位。53例患者实现了骨愈合,注入这些患者骨不连部位的骨髓中祖细胞含量>1500个/cm³,平均总数为54962±17431个祖细胞。在未实现骨愈合的7例患者的骨不连部位注入祖细胞的浓度(634±187个祖细胞/cm³)和总数(19324±6843个)均显著低于实现骨愈合的患者(分别为p = 0.001和p < 0.01)。在实现骨愈合的患者的计算机断层扫描中,四个月时测量的矿化骨痂体积为0.8至5.3 cm³(平均为3.1 cm³)。四个月时矿化骨痂体积与移植物中成纤维细胞集落形成单位的数量(p = 0.04)和浓度(p = 0.01)呈正相关。获得骨愈合所需的时间与移植物中成纤维细胞集落形成单位的浓度呈负相关(p = 0.04)。
经皮自体骨髓移植是治疗萎缩性胫骨干骨不连的一种有效且安全的方法。然而,其疗效似乎与移植物中祖细胞的数量有关,在未浓缩的情况下,从髂嵴抽取的骨髓中可用的祖细胞数量似乎并不理想。